TYPE: NT 10-K
SEQUENCE: 1
U.S. SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C.
FORM 12b-25
NOTIFICATION OF LATE FILING SEC File Number 0-14189
[x] Form 10-K and Form 10-KSB [ ] Form 20-F [ ] Form 10-Q and Form 10-QSB [ ]
Form N-SAR
For Period Ended: September 30, 1998 [x] Transition Report on Form 10-Q [ ]
Transition Report on Form 10-K [ ] Transition Report on Form N-SAR
Transition Report on Form 20-F [ ] Transition Report on Form 11-K [ ]
For the Transition Period Ended:_________________
===============================================================================
Nothing in this form shall be construed to imply that the Commission has
verified any information contained herein.
===============================================================================
If the notification relates to a portion of the filing checked above,
identify the Item(s) to which the notification relates:
===============================================================================
Part I - Registrant Information
===============================================================================
Full Name of Registrant: Interwest Home Medical, Inc.
Former Name if applicable:
Address of Principal Executive Office:
235 East 6100 South
Salt Lake City, UT 84107
===============================================================================
Part II - Rules 12b-25(b) and (c)
===============================================================================
If the subject report could not be filed without unreasonable effort or
expense and the registrant seeks relief pursuant to Rule 12b-25(b), the
following should be completed.
[ ] (a) The reasons described in reasonable detail in Part III of this form
could not be eliminated without unreasonable effort or expense;
<PAGE>
[x] (b) The subject annual report, semi-annual report, transition report on Form
10-K, Form 20-F, 11-K or Form N-SAR, or portion thereof will be filed on or
before the fifteenth calendar day following the prescribed due date; or the
subject quarterly report or transition report on Form 10-Q, or portion thereof
will be filed on or before the fifth calendar day following the prescribed due
date; and
[ ] (c) The accountant's statement or other exhibit required by Rule 12b- 25(c)
has been attached if applicable.
===============================================================================
Part III - Narrative
===============================================================================
State below in reasonable detail the reasons why Form 10-K and Form 10-KSB,
20-F, 11-K, 10-Q and Form 10-QSB, N-SAR, or the transition report or portion
thereof could not be filed within the prescribed period.
The Company desires an extension for filing its form 10KSB as additional
time is required to finalize the consolidation of the Company's subsidiaries and
the audit procedures have not been completed for the Company's annual audit.
===============================================================================
Part IV - Other Information
===============================================================================
(1) Name and telephone number of person to contact in regard to this
notification:
James E. Robinson, Chief Executive Officer
235 East 6100 South
Salt Lake City, UT 84107
(801) 261-5100
(2) Have all other periodic reports required under section 13 or 15(d) of
the Securities Exchange Act of 1934 or section 30 of the Investment Company Act
of 1940 during the preceding 12 months or for such shorter period that the
registrant was required to file such report(s) been filed? If the answer is no,
identify report(s).
[x] Yes [ ] No
(3) Is it anticipated that any significant change in results of operations
from the corresponding period for the last fiscal year will be reflected by the
earnings statements to be included in the subject report or portion thereof?
[ ] Yes [X ] No Presently unknown.
<PAGE>
If so, attach an explanation of the anticipated change, both narratively
and quantitatively, and, if appropriate, state the reasons why a reasonable
estimate of the results cannot be made.
Interwest Home Medical, Inc. has caused this notification to be signed on
its behalf by the undersigned thereunto duly authorized.
Date: December 29, 1998 By: /s/ James E. Robinson
James E. Robinson
Chief Executive Officer
===============================================================================
ATTENTION
Intentional misstatements or omissions of fact constitute Federal Criminal
Violations (See 18 U.S.C. 1001).
